Univadis - a service form MSD

A trusted medical reference

Create an account Log in

app catalog Search

Log in

Close

My Account

Loading...

Medical News Medical Quiz eLearning Conference Reports Delete Oncology Radiology Collection Delete PubMed Delete Image & Media Library Delete Link Library Delete MSD Manual Delete Patient Resource Centre Install new apps

See all my apps Hide my apps

Install new apps Manage my apps

Rearrange your apps by dragging them or delete them with the cross.

Save Cancel

Welcome. Please log in or create an account.

Log in

Remember me (Uncheck if on a shared computer)

Forgot your Password ?

Please review the fields marked in red and resubmit the form

Create an account

Register to access independent medical news and resources from Univadis^®

Latest updates

Medical News

The outbreak has been classified by the WHO as a level 3 emergency, the most serious category.

Ebola outbreak declared Public Health Emergency of International Concern

Univadis Medical News
22 July 2019

The outbreak has been classified by the WHO as a level 3 emergency, the most serious category.

Early introduction of infant-safe peanut protein to reduce the risk of peanut allergy.

Five things to know about preventing peanut allergy in infants

Univadis Medical News
22 July 2019

Early introduction of infant-safe peanut protein to reduce the risk of peanut allergy.

A new study suggests that over half of patient harm is preventable.

One in 20 patients exposed to preventable harm in medical settings

Univadis Medical News
22 July 2019

A new study suggests that over half of patient harm is preventable.

More Medical News >

Conference Reports

JSMO 2019 - Clinical outcome of salvage chemotherapy for patients with metastatic small bowel adenocarcinoma after oxaliplatin

Oncology Conference Reports
22 July 2019

Limited efficacy of salvage line chemotherapy for Japanese patients with metastatic small bowel adenocarcinoma gives guidance on future drug development

JSMO 2019 - Clinical practice guidelines of cancer drug therapies for the elderly

Oncology Conference Reports
22 July 2019

Japan releases clinical guidelines of cancer drug therapies for its elderly patients

JSMO 2019 - A phase 2 study of regorafenib as second line therapy for patients with GIST

Oncology Conference Reports
21 July 2019

Second line therapy crucial for imatinib-resistant GIST with KIT mutation: regorafenib could play a role

More Conference Reports >

Featured Channels

application icon

Oncology Oncology essentials all in one place

application icon

Zika All you need to know about Zika virus

Keep up with oncology literature in minutes, every day

Get your daily dose of the latest evidence published in your cancer area of practice
Get my daily Newsletter

Univadis^®

Univadis^®, provided by MSD, brings you unbiased, relevant medical news as well as helpful resources for your daily practice at no cost.

Our Partners

Univadis^® brings together premium content publishers that deliver comprehensive and up-to-date medical information.

Contact Us

E-mail Us

Complete contact form >

MSD does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-MSD sources. Please read our Terms of Use for more information

Privacy Policy | Transparency Policy

Copyright © 2019 Aptus Health International, Inc. All rights reserved.